Compare two stocks side-by-side:

YieldMax MSTR Option Income Strategy ETF MSTY | AMEX

$23.27 -$1.59 | -6.40%
Market Cap: $1.83 B
PE Ratio:
52-Week Range: $18.94 - $46.5
1-year Total Return: +210.9%
Dividend Yield (FWD): 104.25%

MicroStrategy Incorporated MSTR | NASDAQ

$299.69 -$24.23 | -7.48%
Market Cap: $77.37 B
PE Ratio: -49.54
52-Week Range: $68.794 - $543
1-year Total Return: +320.2%
Dividend Yield (FWD): 0.00%

1-year Total Returns with DRIP & Price Chart for MSTY and MSTR

1Y 2Y 5Y 10Y All
DRIPCalc.com
MSTY vs MSTR Returns

1-year Performance: Total Return (with DRIP), Diviendeds & Portfolio Value:

MSTY MSTR
Initial Balance $10,000 $10,000
Initial Price $21.19 $71.32
Initial Shares 471.92 140.21
 
Total Dividends $25,032 $0
Last Dividend $2.0216 $0
Estimated Divs $2701 / month $0 / quarter
Yield-on-Cost 114.48% 0%
End Shares 1336.04 (+864.12) 140.21
Last Shares Price $23.27 $299.69
Total End Value $31,090 $42,020
Total Return +210.9% +320.2%
Comparison start date: Feb 22, 2024

Dividend Payments & Dividend Yield Curve

Dividend Payments & Yield - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Dividend Payments & Yield - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A

DRIPCalc PRO - Compare is a dividend stocks research & comparison tool, where you can see side-by-side and visually compare:

Dividend payments & dividend yield curve, earnigns, cash, debt and differnt ratios for 1000s of stocks.

In demo-mode, you can see and compare all reports and charts for AAPL and MSFT stocks. Other stocks are availabe for members of DRIPCalc PRO.

When you sign up for DRIPCalc PRO for just $15/mo and 2 weeks Free Trial with full access, you will be able to compare and research any stock or ETF in our vast database!

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Dividend Safety: Payout & Dividend to Free Cash Flow Ratios

Dividend Payout Ratio - MSTY
14-Day FREE Trial Get Full Access Now!
Dividend Payout Ratio - MSTR
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - MSTY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - MSTR
14-Day FREE Trial Get Full Access Now!

Price charts for MSTY and MSTR.

Share Price - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Price CAGR:1Y: 9.82%2Y: 4.79%5Y: 1.89%10Y: 0.94%
Share Price - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Price CAGR:1Y: 345.44%2Y: 233.22%5Y: 82.02%10Y: 32.51%

Earnings, Revenue, Net Income, Dividends, Cash & Debt, Shares Outstaning, and other charts:

EPS vs PE Ratio - MSTY
14-Day FREE Trial Get Full Access Now!
EPS vs PE Ratio - MSTR
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - MSTY
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - MSTR
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - MSTY
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - MSTR
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - MSTY
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - MSTR
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - MSTY
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - MSTR
14-Day FREE Trial Get Full Access Now!
Cash & Debt - MSTY
14-Day FREE Trial Get Full Access Now!
Cash & Debt - MSTR
14-Day FREE Trial Get Full Access Now!
Revenue - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Revenue CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Revenue - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Revenue CAGR:1Y: -3.04%2Y: -4.58%5Y: -2.00%10Y: -2.08%
Earnings Per Share (EPS) - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY EPS CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Earnings Per Share (EPS) - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR EPS CAGR:1Y: -706.00%2Y: 17.62%5Y: N/A10Y: N/A
Net Income - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Net Income CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Net Income - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Net Income CAGR:1Y: -852.65%2Y: 63.91%5Y: N/A10Y: N/A
EBITDA - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY EBITDA CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EBITDA - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR EBITDA CAGR:1Y: 2,953.41%2Y: 2,203.24%5Y: N/A10Y: N/A
Free Cash Flow - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Free Cash Flow CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Free Cash Flow - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Free Cash Flow CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
Free Cash Flow / Share - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Free Cash Flow / Share CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Free Cash Flow / Share - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Free Cash Flow / Share CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
Stock-Based Comp - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Stock-Based Comp CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Stock-Based Comp - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
Expenses - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Expenses CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Expenses - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Expenses CAGR:1Y: -92.63%2Y: -21.94%5Y: -0.64%10Y: 1.01%
Dividends - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Dividends - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Shares Outstanding - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Shares Outstanding CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Shares Outstanding - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Shares Outstanding CAGR:1Y: 20.60%2Y: 39.51%5Y: 16.56%10Y: 6.86%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Actual Revenue CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
REVENUE: Actual + Estimates - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Actual Revenue CAGR:1Y: -3.04%2Y: -4.58%5Y: -2.00%10Y: -2.08%
EPS: Actual + Estimates - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Actual EPS CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EPS: Actual + Estimates - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Actual EPS CAGR:1Y: -706.00%2Y: 17.62%5Y: N/A10Y: N/A
NET INCOME: Actual + Estimates - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Actual Net Income CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
NET INCOME: Actual + Estimates - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Actual Net Income CAGR:1Y: -852.65%2Y: 63.91%5Y: N/A10Y: N/A
EBITDA: Actual + Estimates - MSTY
14-Day FREE Trial Get Full Access Now!
MSTY Actual EBITDA CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EBITDA: Actual + Estimates - MSTR
14-Day FREE Trial Get Full Access Now!
MSTR Actual EBITDA CAGR:1Y: 2,953.41%2Y: 2,203.24%5Y: N/A10Y: N/A

Ratios, Profit Margins & Return on Capital:

Net Profit Margin - MSTY
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Net Profit Margin - MSTR
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: -876.23%2Y: 71.78%5Y: N/A10Y: N/A
Gross Profit Margin - MSTY
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Gross Profit Margin - MSTR
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: -7.29%2Y: -5.24%5Y: -2.54%10Y: -0.93%
Price to Earnings - MSTY
14-Day FREE Trial Get Full Access Now!
Price to Earnings - MSTR
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - MSTY
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - MSTR
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - MSTY
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - MSTR
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - MSTY
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - MSTR
14-Day FREE Trial Get Full Access Now!

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Values & Dividends for MSTY & MSTR

Based on past 1 years performance, MSTY had share price CAGR of +9.82%, and dividend CAGR of +0.00%.

During same period MSTR had share price CAGR of +320.20%, and dividend CAGR of +0.00%.

Using these CAGR metrics, we can estimate, that your initial $10,000 investment from 10 years ago, with dividends being reinvested (DRIP) should grow and collect dividends as follows:

MSTYMSTR
Start Value$10,000$10,000
Start Share Price$23.27$299.69
Start Shares429.7433.37
  
After 10 years:MSTYMSTR
Final Share Count4,251.6733.37
Dividends Payment$2.02$0.00
Annual Dividends$34,381$0
Share Price$54.05$122,411,017.19
Total Dividends$153,587$0
Final Value$229,797$4,084,587,981

Estimated Future Returns - MSTY
Estimated Future Returns - MSTR

Estimate Dividend Snowball and total future returns for MSTY and MSTR with our dividend (DRIP) calculator.

Above numbers are merely projections based on Dividend and Price CAGR for each stock, and should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these metrics.